Nextseq 1 YR maint illumina INC:1107104 [26-000209]
Active Purchase Order Awarded Last action
- Contract number
- 75N90026P00031
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $60,442
Award facts
- Opportunity
-
- Notice of Intent to Sole Source – Illumina Special Notice · 26000209 · Posted Dec 19, 2025
- Contract value 100% obligated
- $60,442.00 Current and potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- J074 Maint/Repair/Rebuild Of Equipment- Office Machines/Text Processing Sys/Visible Record Equipment
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center awarded a $60,442 firm fixed price purchase order to Illumina, Inc. for one-year maintenance support of two NextSeq 1000 sequencers under its Silver Support Plan. The contract, awarded on November 13, 2025, with an ultimate completion date of November 12, 2026, was procured as a sole-source acquisition under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures. The contracting officer determined that Illumina is the only viable source for maintenance services on this specialized genetic sequencing equipment located at the NIH's Bethesda facility, exempting the procurement from standard competitive requirements. No set-aside designation was utilized.
Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, has established itself as a critical supplier to the NIH and multiple federal agencies through its advanced DNA and RNA sequencing platforms. This contract supports the NIH's scientific research capabilities by ensuring continuous operational availability of NextSeq sequencing instruments essential for genetic analysis and laboratory research. The award aligns with Illumina's broader federal portfolio, which includes significant contracts with agencies such as the CDC, USDA, and VA, demonstrating the company's established expertise and specialized position within the federal genomic sequencing market.
Quick answers
Who was awarded contract 75N90026P00031?
75N90026P00031 was awarded to Illumina, Inc. by NIH Clinical Center (National Institutes of Health) on November 13, 2025.
How much is contract 75N90026P00031 worth?
The government has obligated $60,442 on 75N90026P00031.
Was contract 75N90026P00031 competed?
The extent of competition for 75N90026P00031 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award